[go: up one dir, main page]

GB2283173A - Epidermal composition comprising kojic acid and an ultra-violet light absorbent - Google Patents

Epidermal composition comprising kojic acid and an ultra-violet light absorbent Download PDF

Info

Publication number
GB2283173A
GB2283173A GB9411992A GB9411992A GB2283173A GB 2283173 A GB2283173 A GB 2283173A GB 9411992 A GB9411992 A GB 9411992A GB 9411992 A GB9411992 A GB 9411992A GB 2283173 A GB2283173 A GB 2283173A
Authority
GB
United Kingdom
Prior art keywords
fatty acid
preparation
acid
acid esters
polyoxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9411992A
Other versions
GB9411992D0 (en
Inventor
Shinsuke Honda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP27097293A external-priority patent/JP3661707B2/en
Priority claimed from JP27097093A external-priority patent/JP3661706B2/en
Priority claimed from JP27097193A external-priority patent/JP3656197B2/en
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Publication of GB9411992D0 publication Critical patent/GB9411992D0/en
Publication of GB2283173A publication Critical patent/GB2283173A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

Epidermal composition comprises: (i) kojic acid (5-hydroxy-2-hydroxymethyl-gamma-pyrone) or a derative (especially a glycoside) thereof; (ii) an ultra-violet light absorbent; (iii) at least one of: (A) fatty acid esters (including esters of polyhydric alcohols and sugars); (B) fatty acid glycerides; (C) hydrocarbons; (D) lipids (especially glycerophospholips, sphingophospholipids or sphingoglycolipids); (E) fats or oils; (F) alcohols (including polyhydric alcohols and the alkyl ethers thereof, and sugar alcohols); (G) polyphenols (especially catechin, esters of gallic acid, flavone or tannin). c

Description

PREPARATION FOR EPIDERMIS This invention relates to a preparation for epidermis containing kojic acid and/or its derivative and an ultraviolet light absorbent, which further contains at least one member selected from the group consisting of fatty acid esters and fatty acid glycerides hydrocarbons, lipids and hardened or non-hardened fats and oils alcohols and polyphenols for improving stability and attaining lasting effectiveness of the kojic acid and/or its derivative.
As typical forms of preparation for epidermis, there are illustrated O/W (oil-in-water) emulsions and W/O (water-in-oil) emulsions, which are different from each other in water-to-oil composition ratio and physical properties but are both homogeneous preparations wherein oil phase or aqueous phase are stably emulsified and dispersed with the aid of a surfactant.
Kojic acid and its derivatives are known as useful agents having various excellent properties, as disclosed in Japanese Unexamined Patent Publication No. 55-157509, Japanese Examined Patent Publication No. S56-18569, S58-22151, 858-22152, S58-34446, 860-7961, S60-9722 and S60-10005, Japanese Unexamined Patent Publication No.
S60-137253, Japanese Examined Patent Publication No.
S61-10447 and S61-60801, Japanese Unexamined Patent Publication No. 862-5909, Japanese Examined Patent Publication No. S62-3820 and S63-27322, Japanese Unexamined Patent Publication No. Hl-132502 and Japanese Examined Patent Publication No. H5-30422.
However, kojic acid and its derivatives (hereinafter these being in some cases merely referred to as "kojic acids") are also known as agents which themselves have difficulty in acquiring stability.
Particularly when the kojic acids are incorporated in the aforementioned O/W emulsion or W/O emulsion, it requires a highly sophisticated technique to design a proper formulation. Hence, there has been a pressing need for a technique which provides the kojic acids-containing preparation with enough stability to stand severe distributive machinery without giving unpleasant feeling upon application thereof to skin.
In the case of compounding the kojic acids in various preparations for the epidermis, they are likely to be exposed to ultraviolet light to varying degrees which can be an external cause of their discoloration or decomposition. Thus, it has been the practice to compound an ultraviolet light absorbent in a proper amount to depress damage by irradiation with ultraviolet light.
Examples thereof are illustrated in, for example, Japanese Unexamined Patent Publication No. 862-108804 and S64-83008 and Japanese Examined Patent Publication No. H4-46924.
Many of such ultraviolet light absorbents have a problem with solubility and separate out in the preparation, and fail to fully exhibit their ultraviolet light-absorbing ability, leading to a deteriorated stability of kojic acid.
In order to overcome this defect, solubilizing agents have properly been used. However, the use of oily soiubiiizing agent in a large amount causes a problem of giving an unpleasant feeling such as sticking feeling upon application to skin.
In addition, nonionic surfactants, which are properly used as surfactants upon forming a preparation containing kojic acids for external application in view of depressing coloration, giving a pleasant feeling upon application and being harmless to skin, have weaker emulsifying power in comparison with ionic surfactants and suffer decrease in emulsifying power in the presence of a highly polar ingredient or by the influence of pH level. Therefore, in the kojic acid-containing preparation which is usually adjusted to 4 to 5 in pH, incorporation of a highly polar ultraviolet light absorbent causes the problem of deteriorating emulsion stability with time.
It is, therefore, an object of the present invention to provide a preparation fcr epidermis which solves the above-described problems with the conventional kojic acid-containing preparation, i.e., which does not suffer separation of the ultraviolet light absorbent and has improved stability with time to coloration and decomposition of kojic acid and has an improved lasting effectiveness of the ingredient, and which is formed by adding at least one member selected from the group consisting of fatty acid esters and fatty acid glycerides, hydrocarbons, lipids and hardened or non-hardened fats and oils, alcohols and polyphenols to a preparation for external application containing kojic acid and/or its derivative.
Other objects, features and advantages of the present invention will become apparent from the detailed description of the preferred embodiments of the invention to follow.
As the kojic acid (5-hydroxy-2 hydroxymethl-6 -pyrrone) to be used in the present invention as a first ingredient, a pure product of 5-hydroxy-2-hydroxymethyl- -pyrrone, a fermentation liquor containing kojic acid as a major component obtained by cultivating a known bacterium strain capable of yielding kojic acid; a concentrate of the fermentation liquor; a product obtained by extracting kojic acid from the fermentation liquor and crystallizing the extract; and the like.
As the kojic acid derivatives, those which are disclosed in, for example, Japanese Examined Patent Publication No. S60- 10005, Hl-45472 and H3-74229, and esterified products of kojic acid and kojic acid derivatives wherein sugars are bound to the -CH2OH group at 2-position of kojic acid disclosed in, for example, Japanese Examined Patent Publication No.
s58-22151 and S58-22152 may be used alone or in combination of two or more.
The kojic acid and/or its derivative is compounded in the preparation in an amount of 0. 001 to 10 % by weight, preferably 0. 1 to 5 % by weight, based on the total amount of the preparation for external application.
The ultraviolet light absorbents to be used in the present invention as a second ingredient are not particularly limited. Preferred examples thereof include benzophenone derivatives such as oxybenzone, oxybenzonesulfonic acid, sodium hydroxymethoxybenzophenonesulfonate and dihydroxydimethoxybenzophenone; salicylic acid derivatives such as ethylene glycol salicylate, homomenthyl salicylate and phenyl salicylate; urocanic acid and ethyl urocanate; cinnamic acid derivatives such as 2-ethylhexyl p-methoxycinnamate and octyl methoxycinnamate; p-aminobenzoic acid derivatives such as glyceryl p-aminobenzoate and 2-ethylhexyl p-dimethylaminobenzoate; dibenzoylmethane derivatives such as 4-tert-butyl-4' methoxydibenzoylmethane; and benzotriazoie derivatives such as 2-(2-hydroxy-5-methylphenyl)- benzotriazole.
These compounds may be used alone or in combination of two or more. In addition, other known animal or vegetable extracts having ultraviolet light-absorbing ability may properly be used alone or in combination.
Amounts of these ultraviolet light absorbents are somewhat varied depending upon the kind thereof but, usually, they are used in an amount of 0.001 to 10 % by weight, preferably 0. 1 to 5 % by weight, based on the total amount of the preparation for external application.
As the fatty acid esters to be used in the present invention as a third ingredient, there are illustrated higher alcohol fatty acid esters such as isopropyl adipate, avocado oil fatty acid ethyl ester, isocetyl isostearate, isopropyl isostearate, isodecyl isononanoate, octyl isopaimitate, octyl isopelargonate, octyldodecyl erucate, octyl hydroxystearate, octyldodecyl oleate, oleyl oleate, decyl oleate, dioctyl succinate, hexyldecyl dimethyloctanoate, isocetyl stearate, butyl stearate, octyldodecyl lactate, oleyl lactate, cetyl lactate, myristyl lactate, lauryl lactate, isostearyl palmitate, isopropyl palmitate, octyl palmitate, cetyl palmitate, castor oil fatty acid methyl ester, dimethyl phthalate, eicosanyl propionate, stearyl heptanoate, isostearyl myristate, isocetyl myristate, isotridecyl myristate, isopropyl myristate, octyldodecyl myristate, cetyl myristate, decyl myristate, butyl myristate, myristyl myristate, hexyl laurate, octyldodecyl ricinoleate, cetyl ricinoleate, isopropyl linolate and diisostearyl malate; ethylene glycol fatty acid esters such as ethylene glycol fatty acid ester, ethylene glycol dioctanoate, ethylene glycol dioleate, ethylene glycol distearate and ethylene glycol monostearate; polyethylene glycol fatty acid esters such as ethylene glycol laurate, diethylene glycol dilaurate, poiyoxyi 40 stearate, polyethylene glycol paimitate, poiyoxyethylene coconut oil fatty acid ester (6E.O.), polyethylene glycol myristate, polyethylene glycol monooleate and polyethylene glycol monolaurate; propylene glycol fatty acid esters such as propylene glycol fatty acid ester, self-emulsifiable propylene glycol stearate, propylene glycol monostearate, propylene glycol dioleate, propylene glycol dicaprylate and propylene glycol dicaprylate; glycol fatty acid esters such as neopentylglycol dioctanoate, neopen- tylglycol dicaprylate, butanediol dimontanate and alkylene (18, 20) straight chain glycol monoisostearate; trimethylolpropane fatty acid esters such as trimethylolpropane triisostearate and trimethylolpropane trioctanoate; pentaerythritol fatty acid esters such as pentaerythritol fatty acid (1), pentaerythritol tetraoctanoate and pentaerythritol tetramyristate; sorbitol fatty acid esters such as sorbitol sesquiisostearate, sorbitol sesquioleate, sorbitol trioleate and sorbitol coconut oil fatty acid ester; polyoxyethylene sorbitol fatty acid esters such as polyoxyethylene sorbitol (20E.O.) isostearate, polyoxyethylene sorbitol (20E.O. ) trioleate, polyoxyethylene sorbitol (20E.O.) tristearate, polyoxyethylene sorbitol hexastearate, polyoxy-ethylene sorbitol bees wax, polyoxyethylene coconut oil fatty acid sorbitol ester (20E.O. ) and polyoxyethylene sorbitol (6E.O.) monooleate; and sugar fatty acid esters such as sucrose benzoate, sucrose acetate isobutyrate, sucrose stearate and sucrose ester of coconut oil fatty acid and, as the fatty acid glycerides, there are illustrated glycerol fatty acid esters such as glyceryl arachate, glyceryl isostearate, glyceryl oleate (1), wheat germ oil fatty acid glyceride, mixed fatty acid triglyceride, isopalmitic acid diglyceride, hydrogenated soybean oil fatty acid di glyceride, myristic acid di glyceride, cotton seed fatty acid di glyceride, coconut oil fatty acid di glyceride, hydrogenated soybean oil fatty acid diglyceride, glyceryl stearate malate, sesquioleic acid glyceride, capric and caprylic acid triglyceride, tallow fatty acid triglyceride, myristic acid triglyceride, coconut oil fatty acid triglyceride, saturated fatty acid triglyceride and saturated fatty acid glyceride (2), polyglycerol fatty acid esters such as diglyceryl isostearate, diglyceryl oleate, diglyceryl stearate, diglyceryl diisostearate, tetraglyceryl oleate, tetraglyceryl laurate, hexaglyceryl oleate, hexaglyceryl laurate, decaglyceryl laurate, decaglyceryl diisostearate and decaglyceryl decaoleate; and polyoxyethylene glycerol fatty acid esters such as polyoxy-ethylene glyceryl isostearate, polyoxyethylene glyceryl triiso-stearate, polyoxyethylene glyceryl oleate and polyoxyethylene glyceryl monostearate. Of these, middle-chain fatty acid (containing 6 to 12 carbon atoms) monoglycerides, diglycerides and triglycerides are most preferred. These compounds may be used alone or in combination of two or more.
As the hydrocarbons to be used in the present invention as a third ingredient, there are illustrated paraffinic hydrocarbons and olefinic hydrocarbons such as ,X -olefin oligomers, liquid isoparaffin, plastibase (product of Nippon Squib), poiyisobutylene and polybutene, with those containing 10 or more carbons and having a lower polarity being preferably used.
As the lipids, phospholipids are most preferred, and examples thereof include glycerophospholipids such as phosphatidyl chl oline, phosphatidyl inositol, phos phatidyl ethanol amine and phos phatidyl serine obtained by extraction from natural products such as egg yolk, soybean and corn; sphingophospholipids such as sphingomyeiin and ceramide ciliatin; synthetic phospholipids such as sphingogiycolipid, distearoylphosphatidyl choline and dipalmitoylphosphatidyl choline; etc.
As the hardened or non-hardened fats and oils, there are illustrated, as preferred examples, completely hardened castor oils having a polymerization degree of about 40 to about 100 such as polyoxyethylene hardened castor oil, triisostearic acid polyoxyethylene hardened castor oil, isosstearic acid polyoxyethylene hardened castor oil, lauric acid polyoxyethylene hardened castor oil, polyoxyethylene castor oil and polyoxyethylenesorbitol bees wax. These may be used alone or in combination.As the alcohols to be used in the present invention as a third ingredient, lower alcohols such as ethanol, propanol and isopropanol; higher alcohols such as octyldodecanol, olive oil alcohol, oleyl alcohol, stearyl alcohol, cetostearyl alcohol, decyltetradecanol, hexyldecanol, jojoba alcohol, myristyl alcohol and lauryl alcohol; polyhydric alcohols such as alkylene (containing 15 to 18 carbon atoms) glycol, alkylene (containing 20 to 30 carbon atoms) glycol, ethylene glycol, highly polymerized polyethylene glycol,diglycerin, dipropyl ene glycol, hexylene glycol, polyethylene glycol 200, polyethylene glycol 300, polyethylene glycol 400, polyethylene glycl 600, polyethylene glycol 1000, polyethylene glycol 1500, polyethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 20000, polypropylene glycol 400 and polypropylene glycol 1200; sugaralcohols such as fruit sugar, xylitol, D-xylose, sorbitol, D-sorbitol, glucose, multitol, maltose, D-mznnitol and amylolytic sugaralcohol; and polyhydric alcohol alkyl ethers such as isostearyl glyceryl ether, ethylene glycol ethyl ether, ethylene glycol methyl ether, ethylene glycol monobutyl ether, chimyl alcohol, di ethyl ene glycol ethyl ether, diglyceryl oleyl ether and batyl alcohol are illustrated as preferable examples.
As the polyphenols, pyrogallol; phloroglucinol; catechins such as catechin, epicatechin, gallocatechin, catechin gall ate, gallocatechin gall ate, epicatechin gall ate, epigallocatechin gall ate and epigallocatechin; glucogallin; proanthocyanidin; gallic acid; gallic acid esters such as propyl gallate, isoamyloctyl gall ate and dodecyl gall ate; flavones such as rutin, quercetin, quercetagin, quercetagetin and gossypetin penta-0-galloyl glucose; tannic acid; various tannins such as gallotannin, ellagitannin and condensed tannins extracted from ast--ingent Japanese persimmon or tea; and shikimic acid are illustrated as preferable examples, which may be used alone or in combination of two or more.
Amounts of the third ingredient somewhat varies depending upon the kind thereof but, usually, they are added in an amount of 0.001 to 20 % by weight, preferably 0. 1 to 10 % by weight, based on the total amount of the preparation.
The above-described first to three ingredients may be formed into a preparation for external application in a known manner. Such preparation does not suffer separation of the ultraviolet light absorbent, thus being a stable emulsion preparation having good stability with time, in which the kojic acids show improved stability to coloration and decomposition with time and exhibit lasting effectiveness.
Needless to say, form of the preparation of the present invention is not limited to the emulsion type such as O/W emulsion and W/O emulsion, but may be a transparent type by properly selecting the ingredients. In addition, the present invention may also be applicable as a fundamental technique for forming multi-layer emulsion preparations such as W/O/W or O/W/O emulsions or microcapsule preparations.
The preparation of the present invention for the epidermis is not particularly limited as to application form, and may be widely used in a known application form of medicines, quasi-drugs and cosmetics such as cataplasm, plaster, paste, cream, ointment, aerosol, emulsion, lotion, essence, pack, gel, powder, foundation, suncare, bath salts, and the like.
In forming the preparation of the present invention, various known and conventionally used effective ingredients may optionally be incorporated as the case demands in amounts not spoiling the objects of the present invention. Examples of such known effective ingredients include capillary vasodilators such as carpronium chloride, cepharanthine, vitamin E, vitamin E nicotinate, nicotinic acid, nicotinic acid amide, benzyl nicotinate, ginger tincture and chili tincture; coolers such as camphor, mentol and peppermint oil; antimicrobial agents such as hinokitiol, benzalkonium chloride and undecylenic acid; anti-inflammatory agents such as adrenal cortical hormone, aminocaproic acid, lysozyme chloride, glycyrrhizin and allantoin; fairness-imparting agents such as ascorbic acid and arbutin; various extracts of animal or vegetable origin such as placenta extract, liver extract, lithospermum root extract and extract of culture liquor of lactic acid bacteria.
In addition to the known effective ingredients, various known additives such as humectants, antiseptics, antioxidants, chelating agents, pH-adjusting agents, perfumes and colorants may also be used, as well as a base ingredient such as a fat and oil, within a range of not spoiling the objects of the present invention in the above-described application forms of medicines, quasi-drugs and cosmetics.
The present invention is now described in more detail by reference to experiments and formulations which, however, are not construed to be limitative at all.
Experiment 1 Preparation stability test Method of experiment: Various creams (pH: about 4.5) were prepared according to the formulations shown in Table 1. After placing them in ml (4-ounce) candle bottle, they were stored for 2 months under the severe condition of 50'C while irradiating with ultraviolet light. After 2 months, color difference (AE) was measured (using a color-difference meter, Z-1OO1DP, made by Nihon Denshoku Kogyo). In this occasion, observation of change in appearance (separation of the ultraviolet light absorbent and stability of the emulsion) and evaluation of application feeling were also conducted.
Results of the experiment: As is shown in Table 1, the preparations in accordance with the present invention containing ingredients 1 to 8 suffered no separation of the ultraviolet light absorbent and showed an extremely good emulsion stability. Coloration of kojic acid contained in the preparations was not observed, and application feeling was kept good.
Table 1-1 Tested Samples and Experiment Results
Name of Ingredient Examples 1 2 3 4 5 6 7 8 1. Myristic acid tri- 5.00 5.00 2.00 2 - - - - glyceride 2. Myristyl lactate - 2.00 - - - - 2.00 - 3. Propylene glycol di- - - 5.00 - 0.50 - - oleate 4. Diglyceryl diiso- - - - 0.50 - - - stearate 5. Pentaerythritol - - - - 1.50 - - tetramyristate 6. Sorbitol sesqui- - - - - - 0.50 - isostearate 7. Polyoxyethylene - - - - - - 1.50 sorbitol (20E.O.) tristearate 8. Hydrogenated soy- - - - - - - - 3.00 bean oil fatty acid glyceride 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10. Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - - - 1.00 - - salicylate 14. Octyl methoxycinna- - - - - - 0.50 - 0.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00
18. Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 l9.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 25, Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
- | | Appearance *3 no no no no no no I no no *4 @ @ @ @ @ Color difference 3.4 3.0 2.9 2.5 2.8i 3.1 2.0 2.7 (E) Evaluation *6 z Qo Go 1 Qo @ Qo of feeling *7 Qo O s @ 9 @ I upon app- *8 Oo Co Qo Qo Go Qo C)o Oo lication (*5 *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4: Emulsion state (separation) #: good; #: partly separated; X: separated *5: Standard of evaluation: #:good; #: almost no problem; # : slight problem; X : bad *6: rough feel *7: sticky feel *8: fitness to skin Table 1-2 Tested Samples and Experiment Results
Name of Ingredient Comparative Examples 1 2 3 4 5 6 7 8 9 1. Glyceryl. trimyristate - - - - - - - - 2. Myristyl - - - - - - - - 3. propylene glycol di- - - - - - - - - oleate 4. Diglyceryl diiso- ~ - - - - - - - - stearate 5. Pentaerythritol - - - - - - - - tetramyristate i l 6. Sorbitol sesqui- - - - - - - - - - isostearate 7. Polypoxyethylene - - - - - - - - sorbitol (20 E.O.) tristearate 8. Hydrogenated soy- - - - bean oil fatty acid glyceride 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.0 10. Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4'- l methoxy-dibenzoyl- - - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.5 benzoate 13.Ethylene glycol - i i - - - 1.00 - | - salicylate 14.Octyl methoxycinna- - - - - - - 0.50 - 0.1 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.5 16.Vaseline 2.80 2.80 .80 2.80 2.80 2.80 2.80 2.80 2.8 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.0 18.Natural vitamin E 0.04 0.04 .040.0 0.04 0.04 0.04 0.04 0.0
19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.5 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.7 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.0 0.0 0.0 0.0 0.08 0.08 0.08 0.08 0.0 22.Soln. of sodium dl- 6.0 6.0 6.0 6.0 6.00 6.00 6.00 6.00 6.0 pyrrolidone carboxylate 23.Disodium edetater 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.0 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 | *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
Appearance tyty yes yes yes~ yes~ yes X X X X differencl 9 ': ! 10. 7.2 8.6 8.1 6.5 IColor cn E) I Evaluation *6 O C) 0 & O x X X of feeling *7 upon app- *8 Z 5 X z X d X X lication (*5 *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4:Emulsion state (no separation) 00: | good : partly separated; X: separated *5: Standard of evaluation: # : good; Q : almost no problem;# : slight problem; X : bad *6: rough feel *7: sticky feel *8: fitness to skin Table 1-3
Name of Ingredient Examples 10 11 12 13 14 15 16 17 1. Plastibase 5.00 5.00 2.00 - - - - 2. Soybean phospholipid - 2.00 - - - - 2.00 3. Phosphatidyl choline - 5.00 - 0.50 - - - 4. Sphingomyelin - - - 0.50 - - - 5. Polyoxyethylene - - - - 1.50 - - hardened oil (40E.O.
6. Isostearic acid - - - - - 0.50 - - polyoxyethylene hardened oil (60E.O.
7. Polyoxyethylene - - - - - - 1.50 castor oil 8. Polyoxyethylene - - - - - - - 3.00 sorbitol bees wax 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10. Oxybenzone 1.50 - 0.80 - - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13. Ethylene glycol - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - 0.50 - 0.10 mate 15.Bees wax 14.50 4.50 4.50 4.5014.50 4.50 4.50 4.50 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.)
21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
Appearance *3 no no no no no no no no *4 o 0 0 Color differenct! 3.2 3 1 3.0 2.3 3.0 2 9 2 5 2.3 (A E) Evaluation *6 Qo o Oo Qo Go Co @ .
of feeling *7 @ @ @ @ @ 9 @ O upon app- *8 Qo Qo o Co) o Oc Co5 Qo lication (*5 *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4: Emulsion state (separation) # : good; at : partly separated; X: separated *5:Standard of evaluation: good; : good; # : almost no problem;#; slight problem; X : bad *6: rough feel *7: sticky feel *8: fitness to skin Table 1-4
Name of Ingredient Comparative Examples 10 11 1 12 13 14 15 16 1 17 18 1. Plastibase - - - - - - - - - 2. Soybean phospholipid - - - - - - - - 3. Phosphatidyl choline - - - - - - - - 4. Sphingomyelin - - - - - - - - 5. Polyoxyethylene - - - - - - - - - hardened castor oil a (40E.O.) 6. Isostearic acid polyoxyethylene hardened castor oil I (60E.O.) 7. Polyoxyethylene - - - - - - - - castor oil - 8. Polyoxyethylene - - - - - - - - sorbitol bees wax 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.0 10. Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - - 2.00 0.50 - - - 0.20 methane I 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.5 benzoate 13.Ethylene glycol - - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - - 0.50 - 0.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaselin 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether (25 E.O.)
20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.0 22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.0 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.0 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 *1 25.Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
Appearance *3 1 - j no hes hes es lyes yes yes lyes *41A1X Ix rx < xH x I x T X Fx *4t x Evaluation *6 0 O O | X | X X X X X of feeling *7 a X 'C * < I > s I A E upon app- *8 lication (*5 l y | l *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4: Emulsion state (no separation) Qo: | good; # : partly separated; X: separated *5:Standard of evaluation: good; # : almost no problem; # :slight problem; X : bad *6; rough feel *7: sticky feel *8: fitness to skin Table 1-5
Name of Ingredient | Examples 19 20 21 22 23 24 25 2 1. Octyldodecanol 5.00 5.00 2.00 - - - - 2. Polyethylene glycol r - 12.00 2.00 ~ 400 3. Alkylene (15) glycol - - 5.00 - 0.50 - - 4. Sorbitol - - - 0.50 - - - 5. Isostearyl glyceryl - - - - 1.50 - - ether 6. Epigallocatecbin - - - - - 0.50 - gallate 7. Shikimic acid - - - - - - 1.50 8. Isopropanol - - - - - - - 3.00 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.Oxybenzon 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-bibenzoyl- - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - I - - 11.00 salicylate 14.Octyl methoxycinna- - - - - - 0.50 - 1.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00)7.0017.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.) 20. Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.) | s 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08
22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0 0.02 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
Appearance *3 no no no no no no no no *4 Qo Qo &commat; &commat; O Qo Q) ~ Color difference > 3.0 2.3 2.6 2.2 2.3 2.5 1.9 2.6 (dye) Evaluation *6 Qo Qo Co &commat; C $ of feeling *7 &commat; &commat; Qo Qo GD s ~~~~ upon app- *8 Qo Qo Qo Co, ( & ; Qo lication (*5) *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4: Emulsion state (no separation) good;# : partly separated; X; separated *5: Standard of evaluation: .
good; # ; alamost no problem; # slight problem; X : bad *6: rough feel *7: sticky feel *8: fitness to skin Table 1-6
Name of Ingredient | Comparative Examples 19 20 21 22 23 24 25 26 27 1. Octyldodecanol - - - - - - - - 2. Polyethylene glycol - - - - - - - - 400 3. Alkylene (15) glycol - - - - - - - - - 4. Sorbitol - - - - - - - - 5. Isostearyl glyceryl - - - - - - - - - ether 6. Epigallocatechin - - - - - - - - gallate 7. Shikimic acid - - - - - - - - 8. Ispropanol - - - - - - - - 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.0 10. Oxybenzon 1.50 - 0.80 - - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - - 0.50 - 0.1 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaseline -2.802.8O2.80'2.802.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.5 cetyl ether(25 E.O.) t 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08
22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.0 done carboxylate l 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.0 24.Citric acid *1 *1 - *1 ! *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 | *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 *2 Resilts of the tests
Appearance *3 t ~ yes ye,sQye,s yes yes yes yes *4 X X X 7 9.. 8. 7.7IX .6 8.1 6.5 Color difference i 7 9 (E) Ox Evaluation k6 00 i X ~x X X of feeling *7 D nO n x x upon app- *8 lication (*5) *1: slight amount *2: enough amount to make the total amount 100 % by weight *3: Separation of ultraviolet light absorbent *4: Emulsion state (no separation) # : | good; n : partly separated; X: separated *5:Standard of evaluation: good; #: almost no problem ; # slight problem ; X : bad *6: rough feel *7: sticky feel *8: fitness to skin Experiment 2 Effect of depressing pigmentation of guinea pig induced by UV light Effect of depressing pigmentation was examined using yellowish brown guinea pigs.
Results of the experiment are tabulated in Table 2.
As can be seen from the results in Table 2, the preparations of the present invention show excellent and lasting pigmentation-depressing effect. Method of experiment: Back fur of yellowish guinea pigs was clipped off to lay bare the back skin thereof, and the bare back skin was shaved with an electric razor. Each of the shaved backs was covered with a piece of aluminum foil having four square holes (2.0 x 2.0 cm), and was irradiated with W-B (having 3 SE lamps; 140 mJ/cm2) for 90 seconds a day four times every three days. Each of the preparations obtained in Experiment 1 was applied to the irradiated test site from the initiation of the irradiation three times a day for 20 consecutive days (10 consecutive days in the case of Preps 10-17).
Concentration of the ingredient in the muscle tissue was measured and pigmentation was scored between 13th day and 20th day or on the 10th and 20th day for Preps 10-17) after initiation of W light irradiation.
Blackened degree of tested skin was scored with the naked eye according to the following standard.
Scoring standard: 3: No pigmentation was observed.
2: Slight pigmentation was observed.
1: Middle degree pigmentation was observed.
0: Pigmentation was obserbed to the same degree as on control site (non-treated).
-1: Pigmentation was observed to a stronger degree than on control site (non-treated).
Results of the experiments: The preparations of the present invention were confirmed to immediately show excellent pigmentation-depressing effect.
Table 2-1 Results of experiments
Name of Ingredient Examples 1 2 3 4 5 6 7 8 1. Myristic acid tri- 5.00 5.00 2.00 - - - - - glyceride 2. Myristyl lactate - 2.00 - - - - 2.00 3. Propylene glycol di- - - 5.00 - 0.50 - - oleate 4. Diglyceryl diiso- - - - 0.50 - - - stearate 5. Pentaerythritol - - - - 1.50 - - tetramyristate 6. Sorbitol sesqui- - - - - - 0.50 - isostearate 7. Polyoxyethylene - - - - - - 1.50 sorbitol (20E.O.) tristearate 8. Hydrogenated soybean - - - - - - - 3.00 oil fatty acid glyce ide 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - 0.50 - 0.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 22.Soln. of sodium dl- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 pyrrolidone carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 | *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 Scoring of the effect
Concentration of kojic acid 0.5 0.4 0.4 0.7 0.4 0.6 0.5 0.4 in muscle tissue (ug/g) Degree of pig- 3 3 3 3 3 3 3 3 mentation Days necesxsary 14 15 13 14 15 13 14 15 for obtaining pigmentation curing effect (days) *1: slight amount *2: enough amount to make the total amount 100 % by weight Table 2-2 Results of experiments
Name of Ingredient Comparative Examples 1 2 3 4 5 6 7 8 9 1. Glyceryl trimyristate - - - - - - - - 2. Myristyl lactate - - - - - - - - 3. Propylene glycol di- - - - - - - - - oleate 4. Diglyceryl diiso- - - - stearate 5. Pentaerythritol - - - - - - - - tetramyristate 6. Sorbitol sesqui- - - - - - - - - isostearate 7. Polyoxyethylene - - - - - - - - sorbitol (20 E.O.) tristearate 8. Hydrogenated soy- - - - - - - - - bean oil fatty acid glycaride 9. Xojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.0 10.Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - - 1.00 0.50 - - - 0.20 methane 1 12.Glyceryl p-amino- - benzoate 13.Ethylene glycol - - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - mate 15.Bees wax 4.504.50 4.50 4.50 4.50 4.50 4.50 4.50 4.5 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.8 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.0 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.0
19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.5 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.7 0.7 0.7 0.70 0.70 0.70 0.70 0.7 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.0 22.Soln. of sodium dl- 6.0 6.00 6.00 6.00 6.00 6.00 6.00 6.0 pyrrolidone carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.0 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 *2 Scoring of the effect
Concentration of kojic acid 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 in muscle tissue ( g/g) Degree of pig- 1 1 1 1 1 1 1 1 1 mentation Days necessary 18 9 18 18 19 19 18 19 19 for obtaining pigmentation curing effect (days) *1: slight amount *2: enough amount to make the total amount 100 % by weight Table 2-3 Results of experiments
Name of Ingredient Examples 10 11 12 13 14 15 16 17 1. Plastibase 5.00 5.00 2.00 - - - - 2. Soybenan phospholipid - 2.00 - - - - 2.00 3. Phosphatidyl choline - - 5.00 - 0.50 - - 4. Sphingomyelin - - - 0.50 - - - 5. Polyoxyethylene - - - - 1.50 - - hardened oil (40E.O.
6. Isostearic acid - - - - - 0.50 - polyoxyethylene hardened oil (60E.O.
7. Polyoxyethylene - - - - - - 1.50 castor oil 8. Polyoxyethylene - - - - - - - 3.00 sorbitol bees wax 9 . Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 lO.Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - 0.50 - 0.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16.Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E . 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 l9.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.) 20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 arylether (20 E.O.)
21.Carboxyvinyl polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 22.Sodium dl-Pyrroli- 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 @ *2 *2 *2 Scoring of the effect
Degree of 10th 0 0 0 0 0 0 0 0 pigmen- day tation 20th 3 3 3 3 3 3 3 3 day *1: slight amount *2: enough amount to make the total amount 100 % by weight Table 2-4 Results of experiments
Name of Ingredient Comparative Examples 10 11 12 13 14 15 16 17 18 1. Plastibase - - - - - - - - 2. Soybenan phospholipid - - - - - - - - 3. Phosphatidyl choline - - - - - - - - 4. Sphingomyelin - - - - - - - - 5. Polyoxyethylene - - - - - - - - hardened castor oil (40E.O.) 6. Isostearic acid - - - - - - - - polyoxyethylene hardened castor oil (60E.O.) 7. Polyoxyethylene - - - - - - - - castor oil 8. Polyoxyethylene - - - - - - - - sorbitol bees wax 9. Kojic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.Oxybenzone 1.50 - 0.80 - - - - 11.4-tert-Butyl-4' methoxy-dibenzoyl- - - 1.00 0.50 - - - 0.20 methane 12.Glyceryl p-amino- - - - 0.20 - - 0.10 1.50 benzoate 13.Ethylene glycol - - - - - 1.00 - - salicylate 14.Octyl methoxycinna- - - - - - - 0.50 - 0.10 mate 15.Bees wax 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 16. Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 17.Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 18.Natural vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 19.Polyoxyethylene 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 cetyl ether(25 E.O.)
20.Polyoxyethylene ste- 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.7 aryl ether (20 E.O.) 21.Carboxyvinyl polymer 0.08 0.08 0.0 0.08 0.08 0.08 0.08 0.08 0.08 0.0 22.Sodium dl-Pyrroli- 6.00 6.00 6.0 6.006.00 6.00 6.00 6.00 6.0 done carboxylate 23.Disodium edetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.0 24.Citric acid *1 *1 *1 *1 *1 *1 *1 *1 *1 25,Sodium citrate *1 *1 *1 *1 *1 *1 *1 *1 *1 26.Purified water *2 *2 *2 *2 *2 *2 *2 *2 *2 Scoring of the effect
Degree of 10th 0 0 0 0 0 0 0 0 pigmen- day tation 20th 1 1 1 1 1 1 1 1 day *1: slight amount *2: enough amount to make the total amount 100 % by weight Formulation examples of the present invention are shown b Formulation example 1 [Cream(1)] (% by weight) 1. Kojic acid 1.00 2. Oxybenzonesulfonic acid 0. 50 3. Diisopropyl adipate 2. 00 4. Isopropyl myristate 3. 00 5. Polyoxyethylene cetyl ether (25E.O. ) 5. 00 6. Stearic acid 5.00 7. Avocado oil 1. 00 8. Almond oil 10. 00 9. Solution of sodium dl -pyrrolidonecarboxyl ate 5. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Disodium edetate 0.01 12. Purified water to make 100. 00 Formulation example 2 [Cream(2)] (% by weight) 1. Kojic acid 5.00 2. 4-tert-Butyl-41 -methoxy-dibenzoylmethane 0. 50 3. Octyldodecyl lactate 1.00 4. Myristyl lactate 0. 20 5. Polyoxyethylene lanolin 3. 00 6. Dimethylsiloxane methyl (polyoxyethylene- 3. 00 pol yoxypropyl ene copolymer) 7. Jojoba oil 7.00 8. Decamethylcyclopentasiloxane 3. 00 9. Octamethyl cyclotetrasiloxane 3. 00 10. Dimethylpolysiloxane 5.00 11. Natural vitamin E 0. 04 12. 1 % Solution of sodium hyaluronate 2. 00 13. Carrageenan 1.00 14. Disodium edetate 0. 01 15. Purified water to make 100. 00 Formulation example 3 [Emulsion (1)1 (% by weight) 1. Kojic acid 4.00 2. 2-Ethylhexyl p-methoxycinnamate 2. 00 3. Isostearic acid glyceride 4. 00 4. Stearic acid polyoxyethylene monoglyceride 2. 00 5.Polyoxyethylene cetyl ether (25E.O. ) 0. 50 6. Polyoxyethylene oleyl ether (20E.O.) 1. 00 7. Stearic acid 0. 50 8. Shea butter 0. 50 9. Avocado oil 4. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Quince seed extract 5. 00 12. Xanthan gum 0. 14 13. Disodium edetate 0. 01 14. Purified water to make 100. 00 Formulation example 4 [Emulsion (2)] (% by weight) 1. Kojic acid 0. 50 2. Ethylene glycol salicylate 0. 10 3. Octyl methoxycinnamate 2. 00 4. Coconut oil fatty acid sucrose ester 0. 50 5. Myristyl myristate 4. 00 6. Coconut oil fatty acid monoethanolamide 2. 00 7. Stearic acid 0. 50 8. Myristic acid 0. 50 9. Avocado oil 4. 00 10. Natural vitamin E 0. 04 11. p-Hydroxybenzoic acid ester 0. 20 12. Sodium hyaluronate 5. 00 13. Xanthan gum 0. 14 14. Disodium edetate 0.01 15.Purified water to make 100. 00 Formulation example 5 [Lotion] (% by weight) 1. Kojic acid glucoside 7. 00 2. 4 -tert -Butyl - 4' -methoxy-dibenzoylmethane 2. 00 3. 2-Ethylhexyl p-methoxycinnamate 0. 05 4. Ethylene glycol monostearate 3. 00 5. Polyoxyethylene cetyl ether (60E.O.) 5.00 6. Ginseng extract 2.00 7. Japanese chirate extract 0. 50 8. p-hydroxybenzoic acid ester 0. 10 10. Sodium citrate 0. 30 11. 5 % Solution of elastin hydrolyzate 4.00 12. Disodium edetate 0. 01 13. Purified water to make 100. 00 Formulation example 6 [Cream pack] (% by weight) 1. Ethyl kojate 2.00 2. 4-tert-butyl-4' -methoxy-dibenzoylmethane 0. 50 3. Trimethylolpropane trioctanoate 2.00 4. Oleic acid glyceride 5. 00 5. Stearic acid diethanolamide 5. 00 6. Stearic acid 5.00 7. Myristic acid 0. 50 8.Coconut oil 15.00 9. - Natural vitamin E 0. 04 10. p-Hydroxybenzoic acid ester 0. 20 11. Solution of sodium dl-pyrrolidonecarboxylate 5. 00 12. Disodium edetate 0. 01 13. Purified water to make 100. 00 Formulation example 7 [Ointment] (% by weight) 1. Kojic acid 1.00 2. Oxybenzonesulfonic acid 0. 10 3. Phenyl saiicylate 0. 40 4. Sodium hydroxymethoxybenzophenonesulfonate 1. 00 5. Sorbitol sesquiisostearate 2. 00 6. Coconut oil faty acid monoethanolamide 5. 00 7. Vaseline 10. 00 8. Stearic acid 5. 00 9. Oleic acid 1.00 10. Olive oil 10. 00 11. p-Hydroxybenzoic acid ester 0. 20 12. Carrageenan 5. 00 13. Disodium edetate 0. 01 14. Purified water to make 100. 00 Formulation example 8 [Cataplasm] (% by weight) 1. Kojic acid fructoside 0. 50 2. Glyceryl p-aminobenzoate 4. 00 3. Hexyldecyl dimethyloctanoate 1. 00 4.Stearic acid diethanolamide 3. 00 5. Polyacrylic acid 27. 00 6. Licorice extract (ethanol extract) 0. 10 7. Scutellaria root extract (aqueous extract) 0. 05 8. Disodium edetate 0.05 9. Sodium polyacrylate 7. 00 10. Aluminum chloride 0. 30 11. Conc. glycerin 20. 00 12. Titanium oxide 4.00 13. Purified water to make 100. 00 Formulation example 9 [Essence] (% by weight) 1. Kojic acid 1.00 2. Urocanic acid 0. 50 3. 2-Ethylhexyl p-methoxycinnamate 1. 00 4. Polyoxyl 40 stearate 0. 50 5. Octyldodecyl myristate 1. 50 6. Coconut oil fatty acid monoethanolamide 2. 00 7. Stearic acid 0. 50 8. Linoienic acid 0. 50 9. Avocado oil 2. 00 10. Turtle oil 3. 00 11. Natural vitamine E 0. 04 12. p-Hydroxybenzoic acid ester 0. 20 13. 1 % Aqueous solution of carboxyvinyl polymer 5.00 14. Xanthane gum 0. 14 15. Disodium edetate 0.01 16.Purified water to make 100. 00 Formulation example 10 [Cream(l)l (% by weight) 1. Kojic Acid 1.00 2. Oxybenzonesulfonic acid 0. 50 3. Phosphatidyl choline 2. 00 4. Polyoxyethylene hardened castor oil (OE.O. ) 3. 00 5. Polyoxyethylene cetyl ether (25E.O.) 5. 00 6. Stearic acid 5. 00 7. Avocado oil 1.00 8. Almond oil 10. 00 Solution of sodium dl-pyrrolidonecarboxylate 5. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Disodium edetate 0.01 12. Purified water to make 100. 00 Formulation example 11 [Cream(2)] (% by weight) 1. Kojic acid 5.00 2. 4 -tert -Butyl - 4' -methoxy-dibenz oyl methane 0. 50 3. Phosphatidyl ethanolamine 1. 00 4. Polyoxyethylene castor oil 0. 20 5. Plastibase 3. 00 6. Polyoxyethylene hydrous lanolin 3. 00 7. Jojoba oil 7.00 8. Decamethylcyclopentasiloxane 3.00 9.Octamethylcyclotetrasiloxane 3. 00 10. Dimethylpolysiloxane 5. 00 11. Natural vitamin E 0. 04 12. 1 % Solution of sodium hyaluronate 2.00 13. Carrageenan 1.00 14. Disodium edetate 0.01 15. Purified water to make 100. 00 Formulation example 12 [Emulsion (1)] (% by weight) 1. Kojic acid 4. 00 2. 2-Ethylhexyl p-methoxycinnamate 2. 00 3. Squalane 4. 00 4. Ceramide 2. 00 5. Polyoxyethylene cetyl ether (25E.O.) 0. 50 6. Polyoxyethylene oleyl ether 1. 00 7. Stearic acid 0. 50 8. Shea butter 0. 50 9. Avocado oil 4. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Quince seed extract 5. 00 12. Xanthane gum 0. 14 13. Disodium edetate 0.01 14. Purified water to make 100. 00 Formulation example 13 [Emulsion (2)] (% by weight) 1. Kojic acid 0.50 2. Ethylene glycol salicylate 0. 10 3. Octyl methoxycinnamate 2. 00 4. Poiyoxyethylene sorbitol bees was 0. 50 5.Light liquid paraffin 4. 00 6. Coconut oil fatty acid monoethanolamide 2. 00 7. Stearic acid 0. 50 8. Myristic acid 0. 50 9. Avocado oil 4. 00 10. Natural vitamin E 0. 04 11. p-Hydroxybenzoic acid ester 0. 20 12. Sodium hyaluronate 5.00 13. Xanthane gum 0. 14 14. Disodium edetate 0.01 15. Purified water to make 100. 00 Formulation example 14 [Lotion] (% by weight) 1. Kojic acid glucoside 7. 00 2. 4-tert-Butyl-4' -methoxy-dibenzoylmethane 2. 00 3. 2-Ethylhexyl p-methoxycinnamate 0. 05 4. Lauric polyoxyethylene hardened castor oil(100E.O.)3.00 5. Polyoxyethylene cetyl ether (60E.O.) 5. 00 6. Ginseng extract 2. 00 7. Japanese chirate extract 0. 50 8. p-hydroxybenzoic acid ester 0. 10 9. Ascorbic acid 0. 10 10. Sodium citrate 0. 30 11. 5 % Solution of elastin hydrolyzate 4.00 12. Disodium edetate 0.01 13. Purified water to make 100. 00 Formulation example 15 [Cream pack] (% by weight) 1. Ethyl kojate 2.00 2. 4-tert-Butyl-4' -methoxy-dibenzoylmethane 0. 50 3. Triisostearic acid polyoxyethylene hardened 2. 00 castor oil (100E.O.
4. Phosphatidyl inositol 5.00 5. Stearic acid diethanolamide 5. 00 6. Stearic acid 5. 00 7. Myristic acid 0. 50 8. Coconut oil 15. 00 9. Natural vitamin E 0. 04 10. p-Hydroxybenzoic acid ester 0. 20 11. Solution of sodium dl -pyrrolidonecarboxyl ate 5. 00 12. Disodium edetate 0. 01 13. Purified water to make 100. 00 Formulation example 16 [Ointment] (% by weight) 1. Kojic acid 1. 00 2. Oxybenzonesulfonic acid 0. 10 3. Phenyl salicylate 0. 40 4. Sodium hydroxymethoxybenzophenonesulfonate 1. 00 5. Plastibase 2. 00 6. Coconut oil faty acid monoethanolamide 5. 00 7. Vaseline 10. 00 8. Stearic acid 5. 00 9. Oleic acid 1. 00 10. Olive oil 10. 00 11. p-Hydroxybenzoic acid ester 0. 20 12. Carrageenan 5.00 13. Disodium edetate 0.01 14. Purified water to make 100. 00 Formulation example 17 [Cataplasm] (% by weight) 1. Kojic acid fructoside 0.50 2. Glyceryl p-aminobenzoate 4. 00 3. . Isostearic acid polyoxyethylene hardened 1. 00 castor oil 4. Stearic acid diethanolamide 3. 00 5. Polyacrylic acid 27. 00 6. Licorice extract (ethanol extract) 0. 10 7. Scutellaria root extract (aqueous extract) 0. 05 8. Disodium edetate 0. 05 9. Sodium polyacrylate 7. 00 10. Aluminum chloride 0. 30 11. Conc. glycerin 20. 00 12. Titanium oxide 4. 00 13. Purified water to make 100. 00 Formulation example 18 [Essence] (% by weight) 1. Kojic acid 1.00 2. Urocanic acid 0. 50 3. 2-Ethylhexyl p-methoxycinnamate 1. 00 4. Liquid isopraffin 0. 50 5. Dipalmitoyl phosphatidyl choline 1. 50 6. Coconut oil fatty acid monoethanolamide 2. 00 7. Stearic acid 0. 50 8. Linolenic acid 0. 50 9. Avocado oil 2. 00 10. Turtle oil 3. 00 11.Natural vitamine E 0. 04 12. p-Hydroxybenzoic acid ester 0. 20 13. 1 % Aqueous solution of carboxyvinyl polymer 5. 00 14. Xanthan gum 0. 14 15. Disodium edetate 0.01 16. Purified water to make 100. 00 Formulation example 19 [Cream(1)] ( by weight) 1. Kojic acid 1.00 2. Hydroxybenzenesulfonic acid 0. 50 3. Mannitol 2. 00 4. Polyethylene glycol 400 3. 00 5. Polyoxyethylene cetyl ether (25E.O.) 5. 00 6. Stearic acid 5. 00 7. Avocado oil 1. 00 8. Almond oil 10. 00 9. Solution of sodium dl-pyrrolidonecarboxylate 5. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Disodium edetate 0.01 12. Purified water to make 100. 00 Formulation example 20 [Cream(2)] (% by weight) 1. Kojic acid 5. 00 2. 4-tert-Butyl-4' -methoxy-dibenzoylmethane 0. 50 3. Jojoba alcohol 1.00 4. Sorbitol 3. 00 5.Epicatechin gall ate 0. 50 6. Dimethylsiloxane-methyl (polyoxyethylene- 3. 00 polyoxypropylene copolymer) 7. jojoba oil 7.00 8. Decamethylcyclopentasiloxane 3.00 9. Octamethylcyclotetrasiloxane 3. 00 10. Dimethylpolysiloxane 5. 00 11. Natural vitamin E 0. 04 12. 1 % Solution of sodium hyaluronate 2. 00 13. Carrageenan 1.00 14. Disodium edetate 0.01 15. Purified water to make 100. 00 Formulation example 21 [Emulsion (1)j (% by weight) 1. Kojic acid 4.00 2. 2-Ethylhexyl p-methoxycinnamate 2. 00 3. Polyethylene glycol 4000 3. 00 4. Octyl dodecanol 3. 00 5. Polyoxyethylene cetyl ether (25E.O.) 0. 50 6. Polyoxyethylene oleyl ether (20E.O.) 1. 00 7. Stearic acid 0. 50 8. Shea butter 0. 50 9. Avocado oil 4. 00 10. p-Hydroxybenzoic acid ester 0. 20 11. Quince seed extract 5.00 12. Xanthane gum 0. 14 13.Disodium edetate 0.01 14. Purified water to make 100. 00 Formulation example 22 [Emulsion (2)] (% by weight) 1. Rojic acid 0. 50 2. Ethylene glycol salicylate 0. 10 3. Octyl methoxycinnamate 2. 00 4. Batyl alcohol 3. 50 5. Shikimic acid 2. 00 6. Coconut oil fatty acid monoethanolamide 2. 00 7. Stearic acid 0. 50 8. Myristic acid 0. 50 9. Avocado oil 4. 00 10. Natural vitamin E 0. 04 11. p-Hydroxybenzoic acid ester 0. 20 12. Sodium hyaluronate 5.00 13. Xanthane gum 0. 14 14. Disodium edetate 0.01 15. Purified water to make 100.00 Formulation example 23 [Lotion] (% by weight) 1. Kojic acid glucoside 7. 00 2. 4-tert-Butyl-4' -methoxy-dibenzoylmethane 2. 00 3. 2-Ethyihexyl p-methoxycinnamate 0. 05 4. Ethylene glycol ethyl ether 3.00 5.Polyoxyethylene cetyl ether (60E.O.) 5. 00 6. Ginseng extract 2. 00 7. Japanese chirate extract 0. 50 8. p-hydroxybenzoi.c acid ester 0. 10 9. Ascorbic acid 0. 10 10. Sodium citrate 0. 30 11. 5 % Solution of elastin hydrolyzate 4.00 12. Disodium edetate 0.01 13. Purified water to make 100.00 Formulation example 24 [Cream pack] (% by weight) 1. Ethyl kojate 2.00 2. 4-tert-Butyl-4'-methoxy-dibenzoylmethane 0.50 3. Decyltetradecanol 2. 00 4. Polyethylene glycol 1500 5. 00 5. Stearic acid diethanolamide 5. 00 6. Stearic acid 5. 00 7. Myristic acid 0. 50 8. Coconut oil 15. 00 9. Natural vitamin E 0. 04 10. p-Hydroxybenzoic acid ester 0. 20 11. Solution of sodium dl pyrrolidonecarboxylate 5. 00 12. Disodium edetate 0. 01 13.Purified water to make 100. 00 Formulation example 25 [Ointment] (% by weight) 1. Kojic acid 1.00 2. Hydroxybenzenesulfonic acid 0. 10 3. Phenyl salicylate 0. 40 4. Sodium hydroxymethoxybenzophenonesulfonate 1. 00 5. Isoamyloctyl gallate 2. 00 6. Coconut oil faty acid monoethanolamide 5. 00 7. Vaseline 10. 00 8. Stearic acid 5.00 9. Oleic acid 1.00 10. Olive oil 10. O0 11. p-Hydroxybenzoic acid ester 0. 20 12. Carrageenan 5.00 13. Disodium edetate 0.01 14. Purified water to make 100. 00 Formulation example 26 [Cataplasm] (% by weight) 1. Rojic acid fructoside 0. 50 2. Glyceryl p-aminobenzoate 4. 00 3. Rutin 1.00 4. Stearic acid diethanolamide 3. 00 5. Polyacrylic acid 27. 00 6. Licorice extract (ethanol extract) 0. 10 7.Scutellaria root extract (aqueous extract) 0. 05 8. Disodium edetate 0. 05 9. Sodium polyacrylate 7. 00 10. Aluminum chloride 0. 30 11. Conc. glycerin 20. 00 12. Titanium oxide 4.00 13. Purified water to make 100. 00 Formulation example 27 [Essence] (% by weight) 1. Rojic acid 1. 00 2. Urocanic acid 0. 50 3. 2 -Ethylhexyl p-methoxycinnamate 1. 00 4. Isopropanol 0. 50 5. Benzyl alcohol 0. 05 6. Xylose 1. 50 7. Coconut oil fatty acid monoethanolamide 2. 00 8. Stearic acid 0. 50 9. Linolenic acid 0. 50 10. Avocado oil 2. 00 11. - Turtle oil 3. 00 12. Natural vitamine E 0.04 13. p-Hydroxybenzoic acid ester 0. 20 14. 1 % Aqueous solution of carboxyvinyl polymer 5. 00 15. Xanthane gum 0. 14 16. Disodium edetate 0.01 17. Purified water to make 100. 00 It has been confirmed that the above-described Formulation Examples 1 to 27 provide preparations having the same satisfactory results as are shown in Tables 1 and 2.

Claims (15)

Claims
1. A preparation for epidermis containing kojic acid and/or its derivative and an ultraviolet light absorbent, which further contains at least one member selected from the group consisting of fatty acid esters and fatty acid giycerides; hydrocarbons, lipids and hardened or non-hardened fats; and oils, alcohols and polyphenols.
2. The preparation for epidermis according to claim 1, wherein said alcohols are those selected from the group consisting of lower alcohols, higher alcohols, sugar alcohols, polyhydric alcohols and polyhydric alcohol alkyl ethers, and said polyphenols are those selected from the group consisting of catechin, esters of gallic acid, flavone and tannin.
3. The preparation for epidermis according to claim 1, wherein said hydrocarbons are those selected from the group consisting of paraffinic hydrocarbons and olefinic hydrocarbons, said lipids are those selected from the group consisting of glycerophospholipids, sphingophospholipids and sphingoglycolipids, and said hardened or non-hardened fats and oils are those selected from the group consisting of polyoxyethylene hardened fats and oils and polyoxyethylene non-hardened fats and oils.
4. The preparation for epidermis according to claim 1, wherein said fatty acid esters are those selected from the group consisting of higher fatty acid esters, ethylene glycol fatty acid esters, polyethylene glycol fatty acid esters, propylene glycol fatty acid esters, glycol fatty acid esters, trimethylolpropane fatty acid esters, pentaerythritol fatty acid esters, sorbitol fatty acid esters, polyoxyethylene fatty acid esters and sugar fatty acid esters and said fatty acid glycerides are those selected from the group consisting of glycerin fatty acid esters, polyglycerin fatty acid esters and pol yoxyethyl enegl yceri n fatty acid esters.
5. The preparation for epidermis according to claim 1, wherein said alcohol is octyldodecanol.
6. The preparation for epidermis according to claim 1, wherein said alcohol is polyethylene glycol.
7. The preparation for epidermis as described in claim 1, wherein said polyphenol is epigallocatechin.
8. The preparation for epidermis according to claim 1, wherein said polyphenol is shikimic acid.
9. The preparation for epidermis as described in any of claims 1 to 8, wherein said kojic acid derivative is kojic acid glycoside.
10. The preparation for epidermis according to claim 9, wherein said kojic acid glycoside is kojic acid glucoside.
11. The preparation for epidermis according to claim 9, wherein said kojic acid glycoside is kojic acid fructoside.
12. The preparation for epidermis according to any of claims 1 to 8, wherein said kojic acid derivative is ethyl koj ate.
13. The preparation for epidermis according to any of claims 1 to 12, wherein said one member is incorporated in an amount of 0.001 to 20 % by weight based on the total amount of the preparation.
14. The preparation for epidermis according to claim 13, wherein said one member is incorporated in an amount of 0. 1 to 10 % by weight based on the total amount of the preparation.
15. The preparation for epidermis according to any of claims 1 to 14, which is in a form selected from the group consisting of cataplasm, plaster, paste, cream, ointment, aerosol, emulsion, lotion, essence, pack, gel, powder, foundation, suncare and bath salts.
GB9411992A 1993-10-28 1994-06-15 Epidermal composition comprising kojic acid and an ultra-violet light absorbent Withdrawn GB2283173A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27097293A JP3661707B2 (en) 1993-10-28 1993-10-28 Topical skin preparation
JP27097093A JP3661706B2 (en) 1993-10-28 1993-10-28 Topical skin preparation
JP27097193A JP3656197B2 (en) 1993-10-28 1993-10-28 Topical skin preparation

Publications (2)

Publication Number Publication Date
GB9411992D0 GB9411992D0 (en) 1994-08-03
GB2283173A true GB2283173A (en) 1995-05-03

Family

ID=27335862

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9411992A Withdrawn GB2283173A (en) 1993-10-28 1994-06-15 Epidermal composition comprising kojic acid and an ultra-violet light absorbent

Country Status (1)

Country Link
GB (1) GB2283173A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0728470A2 (en) * 1995-02-21 1996-08-28 Shiseido Company Limited An ultraviolet light absorbent
EP0847750A3 (en) * 1996-12-11 1998-07-15 Beiersdorf Aktiengesellschaft Sunscreening compositions containing mono- oligoglyceryl compounds as surface-active agents and hydrosoluble UV filters
EP0992236A1 (en) * 1997-06-10 2000-04-12 Sunstar Inc. Skin-lightening cosmetic
WO2007137128A1 (en) * 2006-05-19 2007-11-29 Mary Kay Inc. Glyceryl and glycol acid compounds
US9089131B2 (en) 2013-03-12 2015-07-28 Mary Kay Inc. Preservative system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02200622A (en) * 1989-01-28 1990-08-08 Sansho Seiyaku Co Ltd External agent for suppressing melanogenesis
US4985455A (en) * 1987-01-30 1991-01-15 Sansho Seiyaku Co., Ltd. External preparations free of discoloration
JPH0578383A (en) * 1991-09-18 1993-03-30 Sansho Seiyaku Co Ltd Kojic acid fructoside and skin medicine containing the same for external use
JPH0648935A (en) * 1992-06-02 1994-02-22 Sansho Seiyaku Co Ltd Melamine production-inhibiting external agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985455A (en) * 1987-01-30 1991-01-15 Sansho Seiyaku Co., Ltd. External preparations free of discoloration
JPH02200622A (en) * 1989-01-28 1990-08-08 Sansho Seiyaku Co Ltd External agent for suppressing melanogenesis
JPH0578383A (en) * 1991-09-18 1993-03-30 Sansho Seiyaku Co Ltd Kojic acid fructoside and skin medicine containing the same for external use
JPH0648935A (en) * 1992-06-02 1994-02-22 Sansho Seiyaku Co Ltd Melamine production-inhibiting external agent

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0728470A2 (en) * 1995-02-21 1996-08-28 Shiseido Company Limited An ultraviolet light absorbent
EP0728470A3 (en) * 1995-02-21 1996-12-04 Shiseido Co Ltd An ultraviolet light absorbent
US5716554A (en) * 1995-02-21 1998-02-10 Shiseido Co., Ltd. Ultraviolet light absorbent
EP0847750A3 (en) * 1996-12-11 1998-07-15 Beiersdorf Aktiengesellschaft Sunscreening compositions containing mono- oligoglyceryl compounds as surface-active agents and hydrosoluble UV filters
EP0992236A1 (en) * 1997-06-10 2000-04-12 Sunstar Inc. Skin-lightening cosmetic
EP0992236A4 (en) * 1997-06-10 2002-01-09 Sunstar Inc Skin-lightening cosmetic
US6669932B2 (en) 1997-06-10 2003-12-30 Sunstar Inc. Skin-whitening cosmetic
US7932417B2 (en) 2006-05-19 2011-04-26 Mary Kay Inc. Glyceryl and glycol acid compounds
WO2007137128A1 (en) * 2006-05-19 2007-11-29 Mary Kay Inc. Glyceryl and glycol acid compounds
AU2007253775B2 (en) * 2006-05-19 2012-02-02 Mary Kay, Inc. Glyceryl and glycol acid compounds
US8258121B2 (en) 2006-05-19 2012-09-04 Mary Kay Inc. Glyceryl and glycol acid compounds
US8431731B2 (en) 2006-05-19 2013-04-30 Mary Kay Inc. Glyceryl and glycol acid compounds
EA017935B1 (en) * 2006-05-19 2013-04-30 Мэри Кэй Инк. Composition for skin care and use thereof
US9375391B2 (en) 2006-05-19 2016-06-28 Mary Kay Inc. Glyceryl and glycol acid compounds
US10045921B2 (en) 2006-05-19 2018-08-14 Mary Kay Inc. Glyceryl and glycol acid compounds
US11793737B2 (en) 2006-05-19 2023-10-24 Mary Kay Inc. Glyceryl and glycol acid compounds
US9089131B2 (en) 2013-03-12 2015-07-28 Mary Kay Inc. Preservative system
US9545103B2 (en) 2013-03-12 2017-01-17 Mary Kay Inc. Preservative system

Also Published As

Publication number Publication date
GB9411992D0 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
US5750563A (en) Preparation for epidermis
US5599528A (en) Preparation for epidermis
US5637293A (en) Preparation for epidermis
CA1295257C (en) Skin treatment composition and method
KR930007911B1 (en) External preparation to prevent coloring
KR20100023917A (en) Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
US9883998B2 (en) Methods for lightening skin using arbutin compositions
KR20000028982A (en) Cosmetic and/or dermatological composition containing at least one extract of mulberry, at least one extract of skullcap and at least one salicylic acid derivative
JP5559463B2 (en) Whitening agent containing shikimic acid as active ingredient
JPH06504282A (en) Cosmetic or medicinal preparations
JP2017140431A (en) Composition and/or article with improved solubility of solid active ingredient
DE19720339A1 (en) Treatment or prevention of undesired skin pigmentation
GB2283173A (en) Epidermal composition comprising kojic acid and an ultra-violet light absorbent
JP2010024204A (en) Skin care preparation
EP0375082A2 (en) Cosmetic composition
JPH1036246A (en) Suppressant for melanogenesis and preparation for external use for skin
JPH11222412A (en) Skin preparation for external use
JP2005104962A (en) Dermal external agent
KR20010062535A (en) Cosmetic composition comprising n-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives
TW202308591A (en) Cosmetic
JP2000159656A (en) Agent for promoting synthesis of collagen
DE10206664A1 (en) 6,7-disubstituted 2,2-dialkylchromanes or chromenes as anti-inflammatories
US20050084546A1 (en) Antioxidant and antiactinic tea plant products
JP4326512B2 (en) Whitening agent and whitening cosmetic containing the same
JPH1192328A (en) Skin preparation for external use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)